InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HRC | Ann: Becoming a substantial holder | 09/01/14 | 0 | 387 | |||
|
|||||||
HRC | Ann: Change of Director's Interest Notice Mr | 09/01/14 | 0 | 310 | |||
|
|||||||
HRC | Ann: Change of Director's Interest Notice Mr | 09/01/14 | 0 | 330 | |||
|
|||||||
HRC | Ann: Change of Director's Interest Notice Mr | 09/01/14 | 0 | 251 | |||
|
|||||||
HRC | Ann: Placement of Shares and Directors Continuing | 23/12/13 | 0 | 325 | |||
|
|||||||
HRC | Ann: Results of 2013 Annual General Meeting | 20/12/13 | 0 | 218 | |||
|
|||||||
HRC | Ann: Notice of Annual General Meeting/Proxy Form | 22/11/13 | 0 | 179 | |||
|
|||||||
HRC | Ann: 2013 Full Year Statutory Accounts | 13/11/13 | 0 | 203 | |||
|
See All Discussions